Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mouth Neoplasms × iso-sulfan blue × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Cisplatin 18 Specimen Handling 10 Radiotherapy 10 Cetuximab 10 Magnetic Resonance Spectroscopy 9 Radiotherapy, Intensity-Modulated 8 Carboplatin 7 1,2-diaminocyclohexaneplatinum II citrate 7 pembrolizumab 6 Platinum 6 Paclitaxel 5 Drug Therapy 5 Celecoxib 5 cemiplimab 4 X-Rays 4 Surgical Procedures, Operative 4 Radiation 4 Fluorouracil 4 Biopsy 4 Taxes 3 Standard of Care 3 Docetaxel 3 durvalumab 2 Radiotherapy, Image-Guided 2 RRx-001 2 Practice Guidelines as Topic 2 Observation 2 Nivolumab 2 Injections 2 Fenretinide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07518485 2026-04-08

preReDSeL

Centre Hospitalier Universitaire Vaudois

Phase 2 Not yet recruiting

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡